RETAVASE
RETAVASE
Discontinued
DIN Number
02233013
Drug Class
Human
Market Date
Feb 19, 1999
Company
HC
ekr therapeutics inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02233013
AIG Number0152495001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B01AD07 RETEPLASE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:12.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
RETEPLASEActive
Strength: 10.4 UNIT / VIAL
Monograph: RETEPLASE